Treating the Forgotten Conditions in Skin of Color
Dr. Prince Adotama, MD, FAAD, assistant professor at NYU Langone, discussing the treatment of acne keloidalis nuchae and dissecting cellulitis in an interview for Next Steps in Derm.Melasma and hair loss are two dermatologic conditions that can affect patients with skin of color that commonly receive media attention. But what about impactful conditions that don’t often make headlines? Next Steps in Derm, in partnership with Skin of Color Update, interviewed Dr. Prince Adotama, assistant professor at NYU Langone’s Ronald O. Perelman Department of Dermatology. Watch as Dr. …
Dr. Prince Adotama, MD, FAAD, assistant professor at NYU Langone, discussing the treatment of acne keloidalis nuchae and dissecting cellulitis in an interview for Next Steps in Derm.
Treating Hair Loss in Skin of Color: OTC and Procedural Alopecia Solutions
Dermoscopic view of the scalp used in an article about treating hair loss in skin of color, featuring expert insights on OTC and procedural alopecia solutions. Managing hair loss in patients with skin of color requires a nuanced understanding of both medical and supplemental therapies. In a detailed presentation, Maryanne Senna, MD, explored the evidence behind over-the-counter (OTC) and procedural interventions for various alopecias. As patients increasingly seek supplemental and at-home options, clinicians must be equipped to distinguish between scie …
Dermoscopic view of the scalp used in an article about treating hair loss in skin of color, featuring expert insights on OTC and procedural alopecia solutions.
H1-Antihistamines Therapeutic Cheat Sheet | Part 1
Clinical presentation of chronic spontaneous urticaria on patient skin, showing erythematous wheals and hives, illustrating the primary dermatologic indication for H1-antihistamine therapy.Antihistamines, particularly second-generation histamine H1-receptor antagonists, are widely used in dermatology due to their antihistaminic activity and favorable safety profile characterized by minimal sedation compared with first-generation agents. They primarily act as peripheral H1-receptor antagonists, reducing histamine-mediated effects such as vasodilation, increased vascular permeability, …
Clinical presentation of chronic spontaneous urticaria on patient skin, showing erythematous wheals and hives, illustrating the primary dermatologic indication for H1-antihistamine therapy.
JAK Inhibitors in Dermatology Patients With Skin of Color
Dr. Brett King discussing the clinical use and safety of JAK inhibitors for treating inflammatory skin conditions in patients with skin of color.Dermatologists must become comfortable prescribing JAK inhibitors in patients with skin of color in order to provide high-quality dermatologic care. That’s according to Dr. Brett King, a dermatologist in Fairfield, Conn., who was the first dermatologist to show that JAK inhibitors as a medicine class were effective in treating a spectrum of dermatologic conditions, including alopecia areata and …
Dr. Brett King discussing the clinical use and safety of JAK inhibitors for treating inflammatory skin conditions in patients with skin of color.
JDD Buzz Series | Patient Perspectives on Scalp Biopsies for CCCA
A graphic featuring the text 'PATIENT PERSPECTIVES ON SCALP BIOPSIES FOR CCCA' over a microphotograph of a scalp biopsy sample showing inflammatory cells around a hair follicle.Scalp biopsies are an important tool in diagnosing central centrifugal cicatricial alopecia (CCCA), especially in atypical presentations where making an accurate diagnosis through other means is challenging. Even though a biopsy-confirmed diagnosis could lead to hair-saving treatment, hair loss patients sometimes balk at the recommendation to biopsy. The authors of a brief communication published …
A graphic featuring the text 'PATIENT PERSPECTIVES ON SCALP BIOPSIES FOR CCCA' over a microphotograph of a scalp biopsy sample showing inflammatory cells around a hair follicle.